James T. Boyle Jr., EVP, CEO of Lab Corporate Diagnostics at LABORATORY CORP OF AMERICA HOLDINGS (LH), sold 52,869 shares at $117.19 ($6.2M) on 2016-03-31, disclosed to the SEC on 2016-04-01.
Open-market sale of $6.2M LH by EVP, CEO of Lab Corporate Diagnostics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.85 | 16,605 | $2.0M | 31.6% |
| 2 | $116.67 | 13,191 | $1.5M | 24.9% |
| 3 | $116.67 | 13,191 | $1.5M | 24.9% |
| 4 | $117.19 | 4,941 | $579K | 9.3% |
| 5 | $117.19 | 4,941 | $579K | 9.3% |
| Total | $117.14 avg | 52,869 |
| $6.2M |
| 100% |
| Filing → |
| LH | SELL | 2016-02-16 | $276K | — | Filing → |
| LH | SELL | 2015-04-27 | $176K | — | Filing → |
| LH | SELL | 2015-03-04 | $153K | — | Filing → |